We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
-4.94%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$662M
AUM Growth
-$58.7M
Cap. Flow
-$11.3M
Cap. Flow %
-1.71%
Top 10 Hldgs %
49.89%
Holding
81
New
8
Increased
13
Reduced
33
Closed
10

Top Buys

Rank Stock Value
1
INSM icon
Insmed
INSM
+$25M
2
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$21.4M
3
AMRN
Amarin Corp
AMRN
+$16M
4
TRHC
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
+$11.2M
5
HALO icon
Halozyme
HALO
+$10.1M

Top Sells

Rank Stock Value
1
ARRY
Array Biopharma Inc
ARRY
+$56.2M
2
NKTR icon
Nektar Therapeutics
NKTR
+$25.4M
3
AERI
Aerie Pharmaceuticals
AERI
+$14.1M
4
VTRS icon
Viatris
VTRS
+$10.9M
5
XNCR icon
Xencor
XNCR
+$6.54M

Sector Composition

Rank Sector Weight
1 Healthcare 68.09%
2 Communication Services 8.27%
3 Industrials 1.62%
4 Energy 0.92%
5 Financials 0.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RARE icon
26
Ultragenyx Pharmaceutical
RARE
$2.45B
$7.69M 1.16%
179,659
-358
-0.2% -$19.4K
BMRN icon
27
BioMarin Pharmaceuticals
BMRN
$11.6B
$6.98M 1.06%
103,552
+33,475
+48% +$2.58M
TEVA icon
28
Teva Pharmaceuticals
TEVA
$40.8B
$6.67M 1.01%
969,230
-3,004
-0.3% -$23K
LHCG
29
DELISTED
LHC Group LLC
LHCG
$6.07M 0.92%
53,479
-574
-1% -$69.2K
BMY icon
30
Bristol-Myers Squibb
BMY
$133B
$5.87M 0.89%
115,700
-49,697
-30% -$2.34M
TECH icon
31
Bio-Techne
TECH
$11.2B
$5.52M 0.83%
112,904
-1,060
-0.9% -$53.2K
CSII
32
DELISTED
Cardiovascular Systems, Inc.
CSII
$5.03M 0.76%
105,856
-83,176
-44% -$3.91M
LGND icon
33
Ligand Pharmaceuticals
LGND
$5.76B
$4.93M 0.75%
79,474
-78,660
-50% -$4.94M
TRUP icon
34
Trupanion
TRUP
$1.07B
$4.9M 0.74%
192,797
-1,981
-1% -$58K
TAK icon
35
Takeda Pharmaceutical
TAK
$54.6B
$4.87M 0.74%
283,200
-131,427
-32% -$2.27M
VRTX icon
36
Vertex Pharmaceuticals
VRTX
$121B
$4.51M 0.68%
26,615
-263
-1% -$46.5K
SLP icon
37
Simulations Plus
SLP
$369M
$4.34M 0.66%
125,012
-128,518
-51% -$4.53M
KIDS icon
38
OrthoPediatrics
KIDS
$519M
$4.3M 0.65%
122,016
-1,244
-1% -$43.1K
VTRS icon
39
Viatris
VTRS
$20.4B
$3.72M 0.56%
188,290
-555,494
-75% -$10.9M
QDEL icon
40
QuidelOrtho
QDEL
$1.14B
$3.34M 0.5%
54,369
-574
-1% -$34.5K
TLGT
41
DELISTED
Teligent, Inc
TLGT
$3.05M 0.46%
321,394
-1,306
-0.4% -$10.3K
KDNY
42
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$2.65M 0.4%
499,404
-224,127
-31% -$1.49M
ALXN
43
DELISTED
Alexion Pharmaceuticals
ALXN
$2.62M 0.4%
26,698
-222
-0.8% -$25K
QTTB icon
44
Q32 Bio
QTTB
$466M
$2.58M 0.39%
+7,914
New +$2.69M
ALKS icon
45
Alkermes
ALKS
$8.22B
$2.4M 0.36%
123,107
-104,916
-46% -$2.28M
IBB icon
46
iShares Biotechnology ETF
IBB
$9.34B
$2.11M 0.32%
21,248
– –
EPZM
47
DELISTED
Epizyme, Inc
EPZM
$2.04M 0.31%
198,059
-2,004
-1% -$25.3K
PSCH icon
48
Invesco S&P SmallCap Health Care ETF
PSCH
$163M
$1.96M 0.3%
51,855
– –
IHI icon
49
iShares US Medical Devices ETF
IHI
$3.13B
$1.87M 0.28%
45,480
– –
NVTR
50
DELISTED
Nuvectra Corporation Common Stock
NVTR
$1.81M 0.27%
1,334,512
-3,580
-0.3% -$7.02K
1
2
3 4

Similar funds

AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return

First Light Asset Management's Q3 2019 Portfolio in Review

As of Q3 2019, First Light Asset Management held 81 positions worth $662M, down 8.2% from $720M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

First Light Asset Management's Q3 2019 filing shows 8 new, 13 increased, 33 reduced and 10 closed positions. Its largest new stake was Insmed: 1,294,743 shares worth $22.8M. The largest sale was Array Biopharma Inc, an estimated $56.2M.

By sector, the portfolio is most concentrated in Healthcare at 68% of assets, down from 74% a quarter earlier, followed by Communication Services and Industrials.

  • First Light Asset Management's largest Q3 2019 buy was Insmed: 1,294,743 shares worth $22.8M.
  • First Light Asset Management added most to Halozyme in Q3 2019, an estimated $10.1M increase.
  • First Light Asset Management's biggest Q3 2019 reduction was Viatris, cutting an estimated $10.9M.
  • First Light Asset Management fully exited Array Biopharma Inc in Q3 2019, selling an estimated $56.2M.
  • First Light Asset Management's ten largest holdings make up 50% of its $662M portfolio in Q3 2019.
  • First Light Asset Management opened 8 new positions and closed 10 in Q3 2019.
  • First Light Asset Management's portfolio value fell 8.2% quarter-over-quarter to $662M.

Based on First Light Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.